APM

Aptorum Group Ltd

May 15 • 04:00PM ET

0.8234

-0.0226 -2.67 %

Healthcare • Biotechnology • United Kingdom • Nano • NASD

Index	-	P/E	-	EPS (ttm)	-0.35	Insider Own	34.85%	Shs Outstand	6.35M	Perf Week	-1.98%
Market Cap	6.71M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.31M	Perf Month	-8.51%
Enterprise Value	-2.59M	PEG	-	EPS next Q	-	Inst Own	1.88%	Short Float	0.38%	Perf Quarter	5.21%
Income	-2.07M	P/S	-	EPS this Y	-	Inst Trans	61.31%	Short Ratio	0.44	Perf Half Y	-41.87%
Sales	0.00M	P/B	0.29	EPS next Y	-	ROA	-11.54%	Short Interest	0.02M	Perf YTD	-22.32%
Book/sh	2.84	P/C	1.94	EPS next 5Y	-	ROE	-9.02%	52W High	4.47 -81.58%	Perf Year	-15.98%
Cash/sh	0.42	P/FCF	-	EPS past 3/5Y	59.28% -	ROIC	-8.94%	52W Low	0.65 26.68%	Perf 3Y	-77.63%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.27% 7.75%	Perf 5Y	-96.58%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-1979.68%	Oper. Margin	-	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.78	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	43.90	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.78	EPS Q/Q	-	SMA20	-4.72%	Beta	0.06	Target Price	230.00
Payout	-	Debt/Eq	0.15	Sales Q/Q	-	SMA50	-6.90%	Rel Volume	0.20	Prev Close	0.85
Employees	2	LT Debt/Eq	0.00	Earnings	-	SMA200	-35.17%	Avg Volume	45.50K	Price	0.82
IPO	Dec 18, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	9,070	Change	-2.67%

Apr-15-26 10:00AM	THE Mining Investment Event 2026 Announces Keynote Speakers and Panels, Additional Sponsors and Participating Companies (TMX Newsfile) +7.82%
Apr-14-26 07:00AM	Andean Precious Metals Appoints Victor Flores as Senior Vice President, Exploration, Operations and Growth (TMX Newsfile)
Apr-08-26 07:00AM	Andean Precious Metals Reports Strong First Quarter 2026 Production Results (TMX Newsfile)
Mar-27-26 06:00AM	Andean Advises of Senior Management Change (TMX Newsfile) -8.82%
Mar-25-26 06:00AM	Andean Precious Metals Reports Fourth Quarter and Year-End 2025 Financial Results (TMX Newsfile)
07:00AM	Loading…
Mar-18-26 07:00AM	Andean Precious Metals Announces Inclusion in VanEck Junior Gold Miners ETF (GDXJ) (TMX Newsfile)
Mar-10-26 08:00AM	Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania (GlobeNewswire)
Mar-06-26 04:30PM	Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
Feb-02-26 08:00AM	Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease (GlobeNewswire) -10.22%
Nov-19-25 08:00AM	DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference (GlobeNewswire)
Oct-10-25 09:54AM	Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering (GlobeNewswire) -29.96%
Oct-09-25 08:55AM	As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives (GlobeNewswire)
Sep-05-25 08:00AM	Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire)
Aug-21-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +234.65%
07:07AM	DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR's APOE Genotyping Test (GlobeNewswire)
08:15AM	Loading…
Aug-04-25 08:15AM	Aptorum Group Limited Regains Compliance with NASDAQ's Minimum Bid Price Requirement (GlobeNewswire)
Jul-16-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +100.04%
08:38AM	Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement (GlobeNewswire)
Apr-16-25 12:27PM	Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire) -15.28%
Jan-08-25 06:28AM	Aptorum Group to Issue 1.5 Million Class A Shares (TipRanks) -10.63%
Jan-02-25 10:55AM	Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering (GlobeNewswire) -21.43%
Dec-31-24 10:17AM	Why Aptorum Group (APM) Jumped Nearly 300% at Pre-Market Trading (Insider Monkey) +106.64%
Dec-20-24 04:00PM	Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2024 (Business Wire)
Apr-30-24 09:15AM	Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update (Business Wire) +7.58%
Apr-12-24 06:40AM	7 A-Rated Aggressive Biotech Stocks to Bet On in 2024 (InvestorPlace)
Mar-06-24 08:00AM	Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business (Business Wire) +554.44%
Dec-22-23 04:30PM	Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023 (Business Wire) +10.95%
Dec-21-23 04:30PM	Aptorum Group Limited Announces Results of 2023 Annual General Meeting of Shareholders (Business Wire) +8.96%
Nov-16-23 11:00AM	Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023 (Business Wire)
Aug-10-23 02:57AM	Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets (Business Wire)
02:53PM	Loading…
Aug-05-23 02:53PM	10 Oversold Global Stocks To Buy (Insider Monkey)
Jun-22-23 08:00AM	Aptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma (Business Wire)
Jun-09-23 04:30PM	Aptorum Group Limited Announces Voluntary Delisting from Euronext Paris (Business Wire)
May-05-23 04:31PM	Aptorum Group Receives Nasdaq Notification of Minimum Stockholders Equity Deficiency (Business Wire) +11.23% -31.96%
May-01-23 08:00AM	Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Groups Subsidiary Paths Innovations Limited (Business Wire) +5.53%
06:10AM	Aptorum Group Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
Apr-28-23 09:44AM	Aptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business Update (Business Wire) -10.92%
Mar-27-23 07:00AM	Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group (Business Wire) +9.66%
Mar-17-23 08:15AM	Aptorum Group Limited and ASP Isotopes Inc. Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R) (ACCESSWIRE)
Mar-03-23 07:30AM	Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on its ALS-4, a First-in-Class Small Molecule Drug Targeting Methicillin Resistant Staphylococcus Aureus (Business Wire)
07:30AM	Aptorum Group Announces Completion of End of Phase 1 (EOP1) Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma (Business Wire)
Mar-02-23 07:30AM	Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in China (Business Wire) +10.12%
Feb-10-23 04:30PM	Aptorum Group Regains Compliance with Nasdaq Minimum Bid Price and Receives Nasdaq Notification of Minimum Market Value of Publicly Held Shares Deficiency (Business Wire) -6.25% +7.78%
Feb-06-23 10:08AM	Aptorum Group Limited to Hold Special Extraordinary Meeting of Shareholders on February 21, 2023 (Business Wire) -11.54%
Jan-23-23 06:49AM	Owning 74% in Aptorum Group Limited (NASDAQ:APM) means that insiders are heavily invested in the company's future (Simply Wall St.)
Jan-20-23 08:00AM	Aptorum Group Announces 1-for-10 Reverse Stock Split (Business Wire)
Jan-04-23 09:00AM	Aptorum Group Announces Publication of a Co-authored Paper on its PathsDx Technology - a Rapid-Turnaround Low-Depth Unbiased Metagenomics Sequencing Workflow for Liquid Biopsy based Diagnosis of Infectious Diseases on Illumina Platforms (Business Wire) +7.82%
Dec-22-22 08:00AM	Aptorum Group Limited Announces Results of 2022 Annual General Meeting of Shareholders (Business Wire) +7.31%
Dec-16-22 08:00AM	Aptorum Group Announces Completion of $3 Million Convertible Note due 2023 (Business Wire) +6.38%
Dec-09-22 07:00AM	Aptorum Group Announces Offering of $3 Million Convertible Note due 2023 (Business Wire)
Nov-25-22 08:30AM	Aptorum Group Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) (ACCESSWIRE)
08:00AM	Aptorum Announces Publication of a Co-authored Paper on Development and Validation of a Sensitive Liquid Chromatography with Time-Of-Flight Mass Spectrometry Assay for In Vivo Pharmacokinetic Study of Epigallocatechin-gallate octaacetate (Pro-EGCG) (Business Wire)
Nov-18-22 05:30PM	Aptorum Group Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency (Business Wire)
Nov-08-22 06:00AM	Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 21, 2022 (Business Wire) +5.89%
Oct-07-22 03:40PM	HC Wainwright Initiates Aptorum On Upcoming "Innovative Pipeline" (Benzinga)
Sep-30-22 07:42PM	Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2022 (Business Wire) -7.26%
Sep-23-22 08:00AM	Aptorum Group Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) (ACCESSWIRE)
Sep-15-22 11:58AM	Aptorum Highlights Updates On Clinical Validation of RPIDD Infectious Disease Molecular Diagnostics (Benzinga) +5.52%
08:07AM	Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in Hong Kong (Business Wire)
07:00AM	Aptorum Group Updates on the Clinical Validation of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics (Business Wire)
Sep-02-22 06:45AM	7 Hot Small-Cap Stocks to Buy in September (InvestorPlace) -6.21%
Aug-25-22 08:31PM	Aptorum Group Limited to Present at the H.C. Wainwright Annual Global Investment Conference, September 13-16, 2022 (Business Wire) -7.79%
Aug-19-22 08:30AM	Aptorum Group Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) (ACCESSWIRE) -5.49%
Aug-11-22 09:45AM	Aptorum Group (NASDAQ:APM) shareholders are up 12% this past week, but still in the red over the last three years (Simply Wall St.)
May-17-22 08:13AM	Aptorum Group Limited to Present at the H.C. Wainwright Global Investment Conference, May 23 26 2022 (Business Wire) +5.71%
May-09-22 11:41AM	Here's Why We're Watching Aptorum Group's (NASDAQ:APM) Cash Burn Situation (Simply Wall St.)
May-02-22 08:00AM	Aptorum Group Updates on Data from the Completed Phase 1 Clinical Trial of SACT-1, targeting neuroblastoma (Business Wire)
Apr-29-22 04:00PM	Aptorum Group Limited Reports 2021 Fiscal Year End Financial Results and Provides Business Update (Business Wire)
Apr-25-22 09:30AM	First Patent Regarding RPIDD Infectious Disease Liquid Biopsy Technology DNA Library Preparation and Amplification Methods Granted (Business Wire) -9.86%
Apr-22-22 08:00AM	Aptorum Group Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report® (Business Wire)
Apr-06-22 07:00AM	Andean Precious Metals Announces RSU Grant (Newsfile)
Mar-22-22 05:58PM	Is Andean Precious Metals Corp.'s (CVE:APM) 4.2% ROE Worse Than Average? (Simply Wall St.) -9.27%
Mar-17-22 07:00AM	Andean Precious Metals Reports 2021 Earnings; Delivers on Silver Production and Cost Guidance (Newsfile)
Jan-25-22 10:06AM	SDC Stock Alert: What Has SmileDirectClub Investors Grinning Ear to Ear Today (InvestorPlace) +38.89%
08:21AM	APM Stock Alert: What Is Going on With Little-Known Aptorum Today? (InvestorPlace)
07:45AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jan-20-22 08:47AM	Aptorum Shares Rise After FDA Orphan Drug Tag For Repurposed Compound For Pediatric Cancer (Benzinga) +38.52%
08:00AM	Aptorum Group Receives FDA Orphan Drug Designation for its SACT-1 Repurposed Drug For The Treatment of Neuroblastoma (Business Wire)
Jan-18-22 08:00AM	Aptorum Group Granted The First Patent for its SACT-1 Repurposed Drug For Treatment of Various Cancer Including but Not Limited to Neuroblastoma (Business Wire)
Jan-11-22 04:56AM	Aptorum Group (NASDAQ:APM) investors are sitting on a loss of 90% if they invested three years ago (Simply Wall St.)
Jan-10-22 08:00AM	Aptorum Group Announces Updates on the Clinical Validation of its RPIDD Infectious Disease Liquid Biopsy Technology (Business Wire)
08:00AM	Aptorum Group Announces the Launch of its Oncology and Autoimmune Discovery and Development Platform Targeting Unmet Mutations and Novel Biomarkers (Business Wire)
08:00AM	Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and SACT-1, Small Molecule Drugs Targeted for Infections Caused by Staphylococcus Aureus and Neuroblastoma (Business Wire)
Dec-03-21 08:00AM	Aptorum Group Limited Announces Results of 2021 Annual General Meeting of Shareholders (Business Wire)
Oct-19-21 08:00AM	Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 2, 2021 (Business Wire) -5.30%
Oct-15-21 08:00AM	Aptorum Group Limited Interview to Air on Bloomberg U.S. (Business Wire)
Sep-15-21 09:26AM	Aptorum To Start Testing SACT-1 In Neuroblastoma Patients (Benzinga) +5.32%
08:00AM	Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2021 (Business Wire)
08:00AM	Aptorum Group Limited Has Received IND Clearance From the US FDA to Initiate Clinical Trials for Repurposed Small Molecule Drug SACT-1 for the Treatment of Neuroblastoma (Business Wire)
Aug-03-21 03:01PM	Blue Apron CEO on earnings: What we saw in Q2 was actually very expected (Yahoo Finance Video)
Jul-15-21 02:03AM	What Kind Of Shareholders Hold The Majority In Aptorum Group Limited's (NASDAQ:APM) Shares? (Simply Wall St.)
Jul-12-21 08:59AM	Aptorum Shares Move Higher After Interim Data From Staphylococcus Aureus Candidate (Benzinga)
08:00AM	Aptorum Group Announces Further Positive Interim Results of the Phase 1 Clinical Trial of ALS-4 Targeting Staphylococcus aureus (Business Wire)
Jul-09-21 08:00AM	Aptorum Group Interview to Air on Bloomberg Television U.S. on the RedChip Money Report (Business Wire)
Jun-22-21 04:00PM	Commvault Named 2021 HPE GreenLake Momentum Partner of the Year (PR Newswire)
Jun-21-21 08:30AM	GigaOm Radar Reports Name Commvault a "Leader" and "Outperformer" for Hybrid Cloud Data Protection in Enterprise and SMB Categories; Commvault Rated Top Performer Across All Categories in Both Reports (PR Newswire)
May-26-21 08:00AM	Aptorum Group CEO Subscribed Shares In The Company (Business Wire) +5.34%
May-24-21 12:03PM	Verastem's VS-6766/Defactinib Combo Gets Breakthrough Therapy Tag For Ovarian Cancer; BTIG Upgrades Stock (Benzinga) +17.65%
11:57AM	Aptorum's Shares Jump After ALS-4 Targeting Staphylococcus Aureus Shows Encouraging Action In Early-Stage Study (Benzinga)
08:00AM	Aptorum Group Announces Positive Interim Phase I Clinical Trial Progress for ALS-4 Targeting Staphylococcus aureus and Positive Pre-IND Progress for SACT-1 Targeting Neuroblastoma (Business Wire)

Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.

FounderMr. Chung Yuen Huen

Head of FinanceMr. Kwok Kuen Wong

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

APM

Aptorum Group Ltd

Upgrade your Finviz experience